Quality assessment of PBM protocols for oral complications in head and neck cancer patients: part 2.
Margherita GobboPraveen R AranyElisabetta MerigoRené-Jean BensadounAlan Roger Dos Santos SilvaLuiz Alcino Monteiro GueirosGiulia OttavianiPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)
Quality of life, pain and functional impairment, nutritional status, and survival may be effectively improved with PBM. Given its established efficacy also in reducing RT interruptions and its safety, feasibility, and tolerability, PBM should be included in the field of supportive cancer care in HNC patients. Improved understanding of PBM mechanisms and precise dose parameters is enabling the generation of more robust, safe, and reproducible protocols; thus, it is imperative to support further clinical implementation as well as both applied and basic science research in this novel field.
Keyphrases
- end stage renal disease
- primary care
- ejection fraction
- chronic kidney disease
- healthcare
- public health
- chronic pain
- clinical trial
- newly diagnosed
- open label
- peritoneal dialysis
- pain management
- neuropathic pain
- patient reported
- quality improvement
- patient reported outcomes
- double blind
- spinal cord injury
- study protocol
- free survival